In February 2010, a quadrivalent conjugate vaccine (Menveo; Novartis Vaccines and Diagnostics) was approved by the US FDA to prevent invasive meningococcal disease caused by Neisseria meningitidis ...

LONDON, GREATER LONDON, UNITED KINGDOM, March 10, 2025 /EINPresswire / -- How Has the Menveo Market Performed in Recent Years, and What Does Its Future Hold? The Menveo market has experienced ...

Please consult the full Prescribing Information for additional safety information. Important Safety Information for MENVEO in the US The following is based on the US Prescribing Information for ...

The vaccine, branded as Penmenvy, combines the immune response-generating components of two of the company's approved ...